Cardiovascular disease (CVD) is a leading cause of death worldwide, affecting the heart and blood vessels. Thrombophilia represents a predisposition to form clots inappropriately. It is caused by abnormalities in blood consistency, determined by modified levels and activity of coagulation factors that participate in the “coagulation cascade”.
Thrombotic events are increasingly recognised as a significant source of mortality and morbidity. Predisposition to form clots is a multifactorial disease: it derives from genetic factors, acquired changes in the clotting mechanism, or, more commonly, an interaction between genetic and acquired factors.
A significant proportion of the population has a detectable abnormality, but most of these only develop thrombosis in the presence of additional environmental risk factors. Clonit’s assays provide a complete coverage of frequent as well as rare mutations in genes related to the coagulation pathway reported to constitute risk factors for thrombophilia.
PCR kit for the detection of the Factor XIII V34L mutation
Rapid test for the detectin of Malaria Pf and PAN antigens The Humasis Malaria immunochromatographic assays have been proven to give excellent performance in the WHO RDT Round 5...
PCR kit for the detection of Next Factor V H1299R
Reading template for the LIA products (required for the LiRAS software)
AlethiaTM LAMP based Molecular Solution AlethiaTM now represents the Meridian Bioscience molecular solution formerly known as illumigene. It is a rapid, simple to use...
